The Oncology Insights Podcast Podcast Por Wisenetix arte de portada

The Oncology Insights Podcast

The Oncology Insights Podcast

De: Wisenetix
Escúchala gratis

Obtén 3 meses por US$0.99 al mes + $20 crédito Audible

Hi there, a whole new era of communication in oncology is here. Now you’ve got the sharpest minds in cancer research right in your pocket.

What’s best?

You can listen to them while driving to the hospital, walking between labs, traveling, or just running errands.Now it’s never been this good or this simple.

Welcome to The Oncology Insights Podcast, a monthly podcast where you’ll hear cutting-edge perspectives and what’s working in the world of oncology. Our aspiration is to be the first place you are going to go to find out what's happening, the latest breakthroughs, clinical updates, and innovations in cancer care and research.

All rights reserved.
Enfermedades Físicas Higiene y Vida Saludable Medicina Alternativa y Complementaria Psicología Psicología y Salud Mental
Episodios
  • Dr. Joan Schiller & Dr. Leticia Nogueira: Cancer and Climate | Ep. 05
    Nov 17 2025
    In this episode of The Oncology Insights Podcast, I speak with Dr. Joan Schiller, Co-Founder and Chair of Oncology Advocates United for Climate and Health–International, and Dr. Leticia Nogueira, Scientific Director of Health Services Research at the American Cancer Society. We explore how climate change influences cancer risk, outcomes, and healthcare systems, discussing adaptation, mitigation, and preparedness strategies. Listen now on all major platforms.“Our reliance on fossil fuels increases exposure to carcinogens at every stage, worsening cancer rates and outcomes.” – Dr. Leticia NogueiraMeet the guests: Dr. Joan Schiller is a thoracic oncologist internationally recognized for her research in lung cancer and leadership in advancing awareness of climate change’s impact on cancer. She chairs Oncology Advocates United for Climate and Health – International and has held leading positions at the University of Virginia and UT Southwestern.Dr. Leticia Nogueira, Scientific Director of Health Services Research at the American Cancer Society, is a leading voice studying the intersection of climate, policy, and cancer outcomes.Liked this one? Don’t stop now. Here’s what we think you’ll love!Links to the full research articles and websites:Zhang D, Xi Y, Boffa DJ, Liu Y, Nogueira LM. Association of Wildfire Exposure While Recovering From Lung Cancer Surgery With Overall Survival. JAMA Oncol. 2023 Sep 1;9(9):1214-1220. doi: 10.1001/jamaoncol.2023.2144. PMID: 37498574; PMCID: PMC10375383.Nogueira LM, Sahar L, Efstathiou JA, Jemal A, Yabroff KR. Association Between Declared Hurricane Disasters and Survival of Patients With Lung Cancer Undergoing Radiation Treatment. JAMA. 2019 Jul 16;322(3):269-271. doi: 10.1001/jama.2019.7657. PMID: 31310288; PMCID: PMC6635902.Oncology Advocates United for Climate and Health InternationalNogueira, L.M., Yabroff, K.R. and Bernstein, A. (2020), Climate change and cancer. CA A Cancer J Clin, 70: 239-244. https://doi.org/10.3322/caac.21610Espinel Z, Nogueira LM, Gay HA, Bryant JM, Hamilton W, Trapido EJ, Shepherd JM, Galea S, Shultz JM. Climate-driven Atlantic hurricanes create complex challenges for cancer care. Lancet Oncol. 2022 Dec;23(12):1497-1498. doi: 10.1016/S1470-2045(22)00635-0. Epub 2022 Oct 18. PMID: 36272419.Zhang D, Xi Y, Boffa DJ, Liu Y, Nogueira LM. Association of Wildfire Exposure While Recovering From Lung Cancer Surgery With Overall Survival. JAMA Oncol. 2023 Sep 1;9(9):1214-1220. doi: 10.1001/jamaoncol.2023.2144. PMID: 37498574; PMCID: PMC10375383.Espinel Z, Shultz JM, Aubry VP, Abraham OM, Fan Q, Crane TE, Sahar L, Nogueira LM. Protecting vulnerable patient populations from climate hazards: the role of the nation's cancer centers. J Natl Cancer Inst. 2023 Nov 8;115(11):1252-1261. doi: 10.1093/jnci/djad139. PMID: 37490548; PMCID: PMC11009498.Hantel A, Cernik C, Walsh TP, Uno H, Larios D, Slutzman JE, Abel GA. Assessing the Environmental and Downstream Human Health Impacts of Decentralizing Cancer Care. JAMA Oncol. 2024 Sep 1;10(9):1245-1252. doi: 10.1001/jamaoncol.2024.2744. PMID: 38829310; PMCID: PMC11148788.Smith M, Singh H, Sherman JD. Infection Prevention, Planetary Health, and Single-Use Plastics. JAMA. 2023 Nov 28;330(20):1947-1948. doi: 10.1001/jama.2023.20550. PMID: 37782511.What you will learn:(00:00) Highlight(00:34) Introduction(05:13) Climate events and cancer(08:23) Air pollution link(10:53) Access to care(21:13) Responding to climate risks(25:05) Healthcare system emissions(37:55) Final Questions𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺.Website: The Oncology Insights PodcastInstagram: The Oncology Insights PodcastLinkedIn: The Oncology Insights Podcast
    Más Menos
    43 m
  • Dr. Stephen Nimer: Challenges in Hematologic Cancer Treatment | Ep. 04
    Oct 20 2025

    In this episode of The Oncology Insights Podcast, I speak with Dr. Stephen Nimer, Director of the Sylvester Comprehensive Cancer Center at the University of Miami. We explore his remarkable journey from physician-scientist to national leader in hematologic oncology, focusing on acute myelogenous leukemia (AML) and myelodysplastic syndromes (MDS). We also discuss cellular therapy, precision medicine, and the challenges of translational research in today’s oncology landscape. Listen now on all major platforms!


    “Understanding the interplay between leukemia cells and their microenvironment is essential to identifying effective new therapeutic targets.”


    Meet the guest: Dr. Stephen Nimer is the Director of the Sylvester Comprehensive Cancer Center and Executive Dean for Research at the University of Miami Miller School of Medicine. A leading physician-scientist in hematology-oncology, his research focuses on myelodysplastic syndromes and acute myelogenous leukemia, advancing translational science and patient care.


    Liked this one? Don’t stop now. Here’s what we think you’ll love!


    What you will learn:

    • (00:00) Highlight
    • (00:45) Introduction
    • (12:59) AML treatment challenges
    • (23:22) MDS overview
    • (30:17) Animal research ethics
    • (33:32) Leadership strategy
    • (37:14) Precision medicine
    • (38:52) Final Questions


    𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺.

    Website: The Oncology Insights Podcast

    Instagram: The Oncology Insights Podcast

    LinkedIn: The Oncology Insights Podcast

    Más Menos
    40 m
  • Dr. Yelena Janjigian: Immunotherapy in GI Cancer Care | Ep. 03
    Sep 15 2025

    In this episode of The Oncology Insights Podcast, Dr. Yelena Janjigian, Chief of Gastrointestinal Oncology at Memorial Sloan Kettering Cancer Center, shares results from the global MATTERHORN study and what it means for early-stage gastroesophageal cancer treatment. She explains how immunotherapy is shifting the treatment landscape, the real-world challenges of biomarker access, and why surgical collaboration matters. Listen now on all major platforms!


    "Despite aggressive chemotherapy regimens, the addition of immunotherapy showed improvement in survival and disease-free outcomes."


    Meet the guest: Dr. Yelena Janjigian is a physician-scientist and Chief of the Gastrointestinal Oncology Service at Memorial Sloan Kettering Cancer Center. Her research focuses on the molecular characterization of gastroesophageal cancers, aiming to bring innovative therapies to patients worldwide. With over 140 publications, she is a global leader in GI oncology.


    Liked this one? Don’t stop now. Here’s what we think you’ll love!


    What you will learn:

    • (00:00) Highlight
    • (00:52) Introduction
    • (07:46) Immunotherapy in early-stage
    • (10:26) Trial design challenges
    • (15:03) Regional cancer differences
    • (19:00) Tumor biomarker limitations
    • (24:11) Surgery coordination issues
    • (27:29) Final Questions


    𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺.

    Website: The Oncology Insights Podcast

    Instagram: The Oncology Insights Podcast

    LinkedIn: The Oncology Insights Podcast

    Más Menos
    36 m
Todavía no hay opiniones